These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29452382)

  • 1. Simulated ablation for detection of cells impacting paracrine signalling in histology analysis.
    Taylor-King JP; Baratchart E; Dhawan A; Coker EA; Rye IH; Russnes H; Chapman SJ; Basanta D; Marusyk A
    Math Med Biol; 2019 Mar; 36(1):93-112. PubMed ID: 29452382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma's connections to the tumour microenvironment.
    Brandner JM; Haass NK
    Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine and autocrine regulation of gene expression by Wnt-inhibitor Dickkopf in wild-type and mutant hepatocytes.
    Hartung N; Benary U; Wolf J; Kofahl B
    BMC Syst Biol; 2017 Oct; 11(1):98. PubMed ID: 29029622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response.
    Gangadhara S; Smith C; Barrett-Lee P; Hiscox S
    BMC Cancer; 2016 Jun; 16():345. PubMed ID: 27251376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity.
    Muller KE; Marotti JD; Tafe LJ
    Am J Clin Pathol; 2019 Jun; 152(1):7-16. PubMed ID: 30892594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.
    Dandachi N; Dietze O; Hauser-Kronberger C
    Anticancer Res; 2004; 24(4):2401-6. PubMed ID: 15330190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capturing the Dynamics of a Hybrid Multiscale Cancer Model with a Continuum Model.
    Joshi TV; Avitabile D; Owen MR
    Bull Math Biol; 2018 Jun; 80(6):1435-1475. PubMed ID: 29549576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.
    Cabrera RM; Mao SPH; Surve CR; Condeelis JS; Segall JE
    Breast Cancer Res; 2018 Apr; 20(1):24. PubMed ID: 29636067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.
    Schlüter B; Gerhards R; Strumberg D; Voigtmann R
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1389-400. PubMed ID: 20217132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 gene status in primary breast cancers and matched distant metastases.
    Tapia C; Savic S; Wagner U; Schönegg R; Novotny H; Grilli B; Herzog M; Barascud AD; Zlobec I; Cathomas G; Terracciano L; Feichter G; Bubendorf L
    Breast Cancer Res; 2007; 9(3):R31. PubMed ID: 17511881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models.
    Crafter C; Vincent JP; Tang E; Dudley P; James NH; Klinowska T; Davies BR
    Int J Oncol; 2015 Aug; 47(2):446-54. PubMed ID: 26095475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluorescence in-situ hybridisation with dual-colour in-situ hybridisation for assessment of HER2 gene amplification of breast cancer in Hong Kong.
    Tang SM; Soong IS; Luk MY; Suen DT; Hioe F; Man EP; Tsun OK; Khoo US
    Hong Kong Med J; 2016 Apr; 22(2):144-51. PubMed ID: 26823385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of HER2/neu status: a pilot study comparing HER2/neu dual in situ hybridization DNA probe cocktail assay performed on cell blocks to immunohistochemisty and fluorescence in situ hybridization performed on histologic specimens.
    Hartman AK; Gorman BK; Chakraborty S; Mody DR; Schwartz MR
    Arch Pathol Lab Med; 2014 Apr; 138(4):553-8. PubMed ID: 24678687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification.
    Lee AH; Key HP; Bell JA; Hodi Z; Ellis IO
    J Clin Pathol; 2011 Jun; 64(6):490-2. PubMed ID: 21415056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells.
    Peiris-Pagès M; Sotgia F; Lisanti MP
    Oncotarget; 2015 May; 6(13):10728-45. PubMed ID: 25915429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.
    Yau TK; Sze H; Soong IS; Hioe F; Khoo US; Lee AW
    Hong Kong Med J; 2008 Apr; 14(2):130-5. PubMed ID: 18382020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.